EDWARD AMOAH: Open Payments
NPI 1336101450 · WESLEY CHAPEL, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$529 in 16 payments from 11 companies in 2025. Trend: 2023 $156 · 2024 $243 · 2025 $529
Food & beverage: $529
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 1 | $118 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $115 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $101 |
| Braeburn Inc. | 2 | $40 |
| PFIZER INC. | 2 | $29 |
| ABBVIE INC. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| Abbott Laboratories | 1 | $23 |
| Novo Nordisk Inc | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $18 |
Products named: TZIELD, Kerendia, CAPLYTA, BRIXADI, ELIQUIS, QULIPTA, FARXIGA, FREESTYLE LIBRE 3.
Industry payments across FL — which companies pay providers there.
